Provided by
| Consensus (mean) in EUR million | FY 2024 | FY 2025 | FY 2026 E | FY 2027 E | FY 2028 E |
|---|---|---|---|---|---|
| Orders received | 5,837 | 5,216 | 4,900 | 5,391 | 5,673 |
| - Biomaterial Solutions and Services | 4,392.0 | 3,716.0 | 3,268.5 | 3,568.2 | 3,760.1 |
| - Process Performance Solutions | 1,446.0 | 1,500.0 | 1,631.5 | 1,823.1 | 1,913.5 |
| Net sales | 5,359 | 5,197 | 5,266 | 5,383 | 5,616 |
| - Biomaterial Solutions and Services | 3,922.0 | 3,716.0 | 3,674.9 | 3,591.8 | 3,692.7 |
| - Process Performance Solutions | 1,437.0 | 1,481.0 | 1,594.3 | 1,766.2 | 1,850.4 |
| Comparable EBITA | 609 | 620 | 620 | 679 | 729 |
| - Biomaterial Solutions and Services | 403.0 | 381.0 | 357.0 | 385.3 | 411.7 |
| - Process Performance Solutions | 255.0 | 290.0 | 307.6 | 337.4 | 360.5 |
| Comparable EBITA Margin (%) | 11.4% | 11.9% | 11.8% | 12.6% | 13.0% |
| - Biomaterial Solns. and Servs. | 10.3% | 10.3% | 9.7% | 10.7% | 11.1% |
| - Process Perf. Solns. | 17.7% | 19.6% | 19.3% | 19.1% | 19.5% |
| Adjusted EPS | 1.93 | 1.82 | 2.04 | 2.29 | 2.51 |
| Dividend per share | 1.35 | 1.35 | 1.41 | 1.49 | 1.57 |